PLX
Protalix Biotherapeutics
Description:
Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in Israel, Brazil, the rest of Latin America and internationally. The company is headquartered in Karmiel, Israel.
Address:
2 UNIVERSITY PLAZA, HACKENSACK, NJ, UNITED STATES, 07601
Fiscal year end:
December
Market capitalization:
$244 Million
Dividend per share:
$0.00
How much was you spent on shares:
$1,000
How much will you earn in
10 years:
-72%
How much will you get:
$275
Prices dates:
29-01-2016: $8.50 and 30-01-2026: $2.34